- Home
- GH vs PECO Comparison
GH vs PECO Comparison
Compare GH & PECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- PECO
- Stock Information
- Founded
- GH 2011
- PECO 1991
- Country
- GH United States
- PECO United States
- Employees
- GH N/A
- PECO N/A
- Industry
- GH Medical Specialities
- PECO Real Estate Investment Trusts
- Sector
- GH Health Care
- PECO Real Estate
- Exchange
- GH Nasdaq
- PECO Nasdaq
- Market Cap
- GH 4.3B
- PECO 4.4B
- IPO Year
- GH 2018
- PECO 2021
- Fundamental
- Price
- GH $31.83
- PECO $38.10
- Analyst Decision
- GH Strong Buy
- PECO Buy
- Analyst Count
- GH 14
- PECO 7
- Target Price
- GH $39.93
- PECO $38.33
- AVG Volume (30 Days)
- GH 1.6M
- PECO 839.3K
- Earning Date
- GH 11-06-2024
- PECO 02-06-2025
- Dividend Yield
- GH N/A
- PECO 3.23%
- EPS Growth
- GH N/A
- PECO N/A
- EPS
- GH N/A
- PECO 0.48
- Revenue
- GH $692,256,000.00
- PECO $642,793,000.00
- Revenue This Year
- GH $32.23
- PECO N/A
- Revenue Next Year
- GH $16.90
- PECO $6.08
- P/E Ratio
- GH N/A
- PECO $80.12
- Revenue Growth
- GH 29.20
- PECO 7.00
- 52 Week Low
- GH $15.81
- PECO $30.62
- 52 Week High
- GH $38.53
- PECO $40.12
- Technical
- Relative Strength Index (RSI)
- GH 45.64
- PECO 40.71
- Support Level
- GH $34.20
- PECO $38.85
- Resistance Level
- GH $36.24
- PECO $39.70
- Average True Range (ATR)
- GH 1.70
- PECO 0.68
- MACD
- GH -0.92
- PECO -0.21
- Stochastic Oscillator
- GH 15.98
- PECO 36.76
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About PECO Phillips Edison & Company Inc.
Phillips Edison & Co Inc is a real estate investment trust. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on market of expertise designed to optimize property value and consistently deliver a great shopping experience.